A novel tricyclic BTK inhibitor suppresses B cell responses and osteoclastic bone erosion in rheumatoid arthritis.
Liu YT, Ding HH, Lin ZM, Wang Q, Chen L, Liu SS, Yang XQ, Zhu FH, Huang YT, Cao SQ, Yang FM, Song ZL, Ding J, Geng MY, Xie H, Zhang A, He SJ, Zuo JP.
Liu YT, et al. Among authors: chen l.
Acta Pharmacol Sin. 2021 Oct;42(10):1653-1664. doi: 10.1038/s41401-020-00578-0. Epub 2021 Jan 13.
Acta Pharmacol Sin. 2021.
PMID: 33441995
Free PMC article.